Yesterday, D'Ieteren disclosed its new 2024-2028 ambitions during a CMD in London. In general, D'Ieteren's new ambitions were broadly in line with our expectations and reconfirm the structural growth trends of the recent years. We therefore do not expect major changes to css expectations. While the event did not contain any major surprises, we did get some extra colour on certain topics, with the key new elements summarized below. We further also welcome the solid 1Q25 results at Belron. As the ...
CM.com: CMD – AI-first strategy, new medium-term targets. CVC Capital Partners: Good realisations. D'Ieteren: CMD feedback. Euronext: An even stronger April is Next. Flow Traders: Promising April. KBC: M&A in Slovakia, capital changes, beat in 1Q. Prosus: iFood partners with Uber. SBM Offshore: FY25 starts reasonably well, decarbonization gains momentum. Syensqo: Modest 1Q25 beat, +€1.4bn FY EBITDA guidance excludes FX, tariff impact
Payment of dividend Payment of dividend Regulatory release 14 May 2025, 1 p.m. CET The Ordinary General Meeting of Kinepolis Group NV has decided today to pay out a dividend of € 0.55 gross per share to the shareholders (€ 0.385 net after deduction of 30% withholding taxes). The dividend will be paid out as from 20 May 2025. The ex coupon date is fixed at 16 May 2025 and the record date at 19 May 2025. KINEPOLIS GROUP NV Public limited company that is making or has made a public appeal to savingsEeuwfeestlaan 20, 1020 BrusselsEnterprise Number VAT BE 0415.928.179 RLP Brussels
Paiement dividende Paiement dividende Information réglementée 14 mai 2025, 13h00 L'Assemblée générale ordinaire de Kinepolis Group SA a décidé aujourd’hui de payer aux actionnaires un dividende de 0,55 € brut par action (0,385 € net après déduction du précompte mobilier de 30%). Le dividende sera mis en paiement à partir du 20 mai 2025. La date ex coupon a été fixée au 16 mai 2025 et la date d’enregistrement au 19 mai 2025. KINEPOLIS GROUP SA Société anonyme qui fait ou a fait publiquement appel à l'épargneBoulevard du Centenaire 20, 1020 BruxellesN° d'entreprise TVA BE 0415.928.179...
Dividenduitkering Dividenduitkering Gereglementeerd bericht 14 mei 2025, 13u00 De Gewone Algemene Vergadering van Kinepolis Group NV heeft vandaag besloten een dividend van € 0,55 bruto per aandeel (€ 0,385 netto na aftrek van 30% roerende voorheffing) uit te betalen aan de aandeelhouders. Het dividend wordt betaalbaar gesteld vanaf 20 mei 2025. De ex-coupon datum is vastgesteld op 16 mei 2025 en de record datum op 19 mei 2025. KINEPOLIS GROUP NV Naamloze vennootschap die publiek beroep doet of gedaan heeft op het spaarwezenEeuwfeestlaan 20, 1020 BrusselOndernemingsnummer BTW...
1Q25 was marked by a weak performance in Radiology Solutions (1Q is traditionally a seasonally weak quarter but now with strong impact of the decline of the medical film markets, particularly in China) and the continued strong performance of Agfa's HealthCare IT division, driven by customer adoption of Agfa's cloud technology. While Agfa's Digital Printing Solutions equipment business faced challenges due to economic uncertainty, and the market for Agfa's Zirfon membranes for green hydrogen prod...
This morning D'Ieteren announced its new 2024-2028 ambitions which will be followed by a CMD in London later today. While the mid-single digit adj. EBIT growth target came below our estimate of 7.1%, we believe the outlook is rather prudent as the outlook for the different entities is almost perfectly in line with our expectations. No other major news was announced. While the 1Q25 sales update came in slightly below our estimates , we want to highlight that this was partially due to fewer tradi...
The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline Regulated information May 14, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline Group performance: continued success of the strategic transformation Improved sales mix between growth engines and mature businesses and good cost control compensated for the negative impact of the market ...
De Agfa-Gevaert Groep in het eerste kwartaal van 2025: aangepaste EBITDA stabiel tegenover eerste kwartaal van 2024 – verbeterde mix en goede kostcontrole compenseerde voor de achteruitgang van de filmmarkt Gereglementeerde informatie 14 mei 2025 - 7:45 uur CET De Agfa-Gevaert Groep in het eerste kwartaal van 2025: aangepaste EBITDA stabiel tegenover eerste kwartaal van 2024 – verbeterde mix en goede kostcontrole compenseerde voor de achteruitgang van de filmmarkt Groepsprestatie: voortgezet succes van de strategische t...
Annual General Meeting of Agfa-Gevaert NV - regulated information May 13, 2025 – 5.40 PM CET Regulated information Annual General Meeting of Agfa-Gevaert NV Mortsel, Belgium – May 13, 2025 – 5.40 p.m. CET At Agfa-Gevaert's Annual General Meeting, the 2024 financial statements, the allocation of the result, the remuneration report, the remuneration policy and the discharge of directors and statutory auditor were approved. Furthermore, the shareholders rendered available all share premiums that can be rendered available without specific formaliti...
Jaarlijkse Algemene Aandeelhouders-vergadering van Agfa-Gevaert NV - gereglementeerde informatie 13 mei 2025 – 17u40 CET Gereglementeerde informatie Jaarlijkse Algemene Aandeelhouders-vergadering van Agfa-Gevaert NV Mortsel, België – 13 mei 2025 – 17u40 CET Op de Jaarlijkse Algemene Aandeelhoudersvergadering van Agfa-Gevaert werden de jaarrekening van het boekjaar 2024, de bestemming van het resultaat, het remuneratieverslag en het remuneratiebeleid goedgekeurd. Tevens werd er kwijting verleend aan de bestuurders en de commissaris. Voorts stelden de aandeelhouders alle uitgiftepremies...
Alfen: Dead cat bounce? Ayvens: Overhang cure. Belgian telcos: Hey! discontinues €5 offer, OBEL price increases from June 2025. B&S Group: Pulls FY EBITDA guidance in light of tariffs. D'Ieteren: CMD, 1Q25 Preview. Kendrion: Wrestling through difficult macro conditions. NN Group, ASR: Vote on Dutch pension reforms postponed. TKH Group: Not that bad, good progress at Eemshaven. UCB: US Most Favoured Nation initiative back on the agenda. Vastned: Good results, integration ongoing...
UCB received Japanese approval for two self-administration methods for Rystiggo (anti-FcRn) in generalised myasthenia gravis (gMG), allowing patients to use an infusion pump or manual syringe at home after training. To support the label expansion, UCB also launched a home delivery service in Japan to enhance patient convenience and satisfaction. The move aligns with Rystiggo's self-administration approval in the EU earlier this year and could support its positioning amid growing competition. We ...
AB InBev: Strong brew. Adecco: 1Q25 beats on timing of JV income; 2Q25 outlook momentum positive. Alfen: Preview - 1Q25 should arrive in line. AMG: Strong 1Q25 EBITDA beat, guidance raised. BAM Group: Non-residential backs EBITDA increase. CTP: Strong results combined with strong message on demand dynamics. JDE Peet's: Jumping Beans. Kinepolis: Peer AMC 1Q25 results - revenues per visitor more subdued. Prosus: CEO letter highlights strong profit growth in 2026. Proximus: CpaaS ...
The ongoing tariff war continues to create uncertainty for investors, with a trade embargo between the US and China. Although Europe has received a temporary reprieve, the prolonged situation could result in significant economic damage. We are maintaining a defensive stance in our Benelux Dynamic Top Pick List, as the Federal Reserve holds steady and the European Central Bank may continue lowering rates. Pessimism regarding the European industry has increased, though some US-based European compa...
1M Performance - Absolute: During April'25 (1M period), the KBCS Holdings Universe posted a return of +2.7% which was mainly driven by multi-asset holdings (+3.0%) while single-asset holdings posted a smaller return of +2.0%. The 3 top performers during the period were D'Ieteren (+10.6%), Ackermans & van Haaren (+7.7%) and Groupe Bruxelles Lambert (+5.4%) while the 3 worst performers were Exor (-0.8%), HAL Trust (-1.5%) and Quest for Growth (-5.5%). YTD Performance - Relative: On a YTD basis (a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.